Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase

Learn Mem. 1999 Mar-Apr;6(2):97-110.

Abstract

Fear conditioning has received extensive experimental attention. However, little is known about the molecular mechanisms that underlie fear memory consolidation. Previous studies have shown that long-term potentiation (LTP) exists in pathways known to be relevant to fear conditioning and that fear conditioning modifies neural processing in these pathways in a manner similar to LTP induction. The present experiments examined whether inhibition of protein synthesis, PKA, and MAP kinase activity, treatments that block LTP, also interfere with the consolidation of fear conditioning. Rats were injected intraventricularly with Anisomycin (100 or 300 microg), Rp-cAMPS (90 or 180 microg), or PD098059 (1 or 3 microg) prior to conditioning and assessed for retention of contextual and auditory fear memory both within an hour and 24 hr later. Results indicated that injection of these compounds selectively interfered with long-term memory for contextual and auditory fear, while leaving short-term memory intact. Additional control groups indicated that this effect was likely due to impaired memory consolidation rather than to nonspecific effects of the drugs on fear expression. Results suggest that fear conditioning and LTP may share common molecular mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acoustic Stimulation
  • Animals
  • Brain / anatomy & histology
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology*
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Fear / drug effects
  • Fear / physiology*
  • Fear / psychology*
  • Injections, Intraventricular
  • Long-Term Potentiation
  • Male
  • Memory / drug effects
  • Memory / physiology*
  • Memory, Short-Term / drug effects
  • Memory, Short-Term / physiology
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / physiology
  • Protein Synthesis Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Enzyme Inhibitors
  • Nerve Tissue Proteins
  • Protein Synthesis Inhibitors
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases